Keywords:
Pelvis, Genital / Reproductive system male, MR, Ultrasound, Biopsy, Cancer
Authors:
A. Villa1, F. Chiesa2, I. Rosenberg3, A. Tagliafico4, M. Perinetti5, A. Del Prato5; 1Genova, It/IT, 2Genova (GE)/IT, 3Sarzana/IT, 4Genova/IT, 5Genoa/IT
DOI:
10.1594/ecr2013/C-2333
Results
In our initial experience,
using MRI and US image fusion technique,
6/15 patients were diagnosed with prostate cancer.
Each lesion was categorized by multiparametric MRI in high,
medium and low risk.
When MRI lesion has been marked as highly suspicious,
the detection rate was 100% (4/4); medium 33% (2/6) and low 0% (0/5).
In only one patient prostatic cancer in the same lobe was found both in targeted and in random biopsy.
In the latest case the target specimen had the highest Gleason score (3+4) versus the random biopsy (3+3).
In all the 6 patients with a prostatic cancer diagnosed by targeted biopsy,
disease was not found by random biopsy in the contralateral lobe.
The Gleason score evaluated for each specimen had a higher value in targeted biopsies relative to random biopsies.
Complications post procedures didn’t occur.